30/01/2020
Bruno Canard
Evolution, diversité, réplication des Coronavirus
Articles connexes
-
The bacterial pathogen Listeria Monocytogenes : from cell biology to microbiomes
28/11/2019 Pascale Cossart The bacterial pathogen Listeria Monocytogenes : from cell biology to microbiomes
-
La file d’attente devant l’IHU a disparu : pourquoi ?
Bulletin d'informations scientifiques - Nous avons le droit d'être intelligents ! Pr Didier Raoult - Directeur de l'IHU Méditerranée...
-
Hydroxychloroquine and azithromycin as a treatment of COVID-19
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial pdf article to download: Hydroxychloroquine_final_DOI_IJAA...
-
The strengths of scanning electron microscopy in deciphering SARS-CoV-2 infectious cycle
COVID-IHU #13 Version 1 du 14 Mai 2020 The strengths of scanning electron microscopy in deciphering SARS-CoV-2 infectious cycle...
-
The emergence of sporotrichosis in Brazil
18/01/19 Christiane Lamas The emergence of sporotrichosis in Brazil
-
Randomised Controlled Trials during epidemic
COVID-IHU #18 Version 2 du 18 Juin 2020 Randomised Controlled Trials during epidemic Philippe Brouqui, Didier Raoult In epidemics...
-
Coronavirus : vers une sortie de crise ?
Flash Info Méditerranée Infection Pr Didier Raoult, Directeur de l’IHU Méditerranée Infection
-
Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier)
COVID-IHU #25 Version 1 du 08 Juillet 2020 Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an...
